SAD/MAD study to evaluate safety and PK/PD of BT-600, including concentrations in colon tissue SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc (BIOR). (Nasdaq: BIOR), the biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results